Everett Laboratories, Inc. Files Patent Infringement Lawsuits Against Competitor Acella Pharmaceuticals, LLC

CHATHAM, N.J., July 8, 2013 /PRNewswire/ -- Everett Laboratories, Inc., a leader in the field of nutritional products and prenatal supplementation, today formally announced that it has filed three patent infringement lawsuits and associated motions for preliminary injunctions in the United States District Court for the District of New Jersey against Acella Pharmaceuticals, LLC: (1) Case No. 13-3470 pertaining to Acella's PNV-First product, which is a direct copy of Everett's Vitafol®-One prenatal nutritional supplement product and infringes Everett's U.S. Patent No. 8,183,227; (2) Case No. 13-3487 pertaining to Acella's Choice-OB+DHA, which is a direct copy of Everett's Select-OB®+DHA prenatal nutritional supplement product and infringes Everett's U.S. Patent No. 8,197,855; and (3) Case No. 13-3529 pertaining to Acella's "PNV - OB with DHA" product that is a direct copy of Everett's Vitafol®-OB+DHA prenatal nutritional supplement product and infringes Everett's U.S. Patent No. 6,814,983 and U.S. Patent No. 7,390,509. 

Everett's lawsuits seek to immediately and permanently prevent Acella from making, selling, and distributing in the United States its infringing, copycat products.  Everett has specifically moved in each case for immediate relief, explaining how it will be irreparably harmed unless the court issues a preliminary injunction requiring Acella to immediately withdraw its patent-infringing products from the marketplace.

"Everett provides a unique and innovative portfolio of prenatal vitamins to American women," said Lucas Sigman, Everett's Chief Executive Officer.  "This portfolio is the result of significant research and development efforts.  Our premiere-quality prenatal vitamins are patent-protected.  We will not tolerate infringement of our patents, and we will do what is necessary to protect our proprietary rights."

"With the strength of our R&D plus our strong commercial activities, we have become the leading company in the branded prenatal vitamin segment of the nutritional supplement market, and we will continue working to enforce our patents and consolidate our position," said Louis Bongiovanni, Everett's Senior Vice President of Sales

About Everett Laboratories, Inc.

Everett Laboratories is a New Jersey-based women's healthcare pharmaceutical company that has been providing essential pharmaceutical and nutritional products for four decades.  Everett is a subsidiary of The Chemo Group, a global healthcare corporation based in Spain with a presence in more than 30 countries.  Everett is dedicated to providing advanced treatments and innovative new products to address unmet needs for women and families and to improving women's health.  The company strives to produce and market unique, first-in-class prescription and over-the-counter nutritional products.

Contact: Lucas Sigman, Everett Laboratories
973.324.0200 

SOURCE Everett Laboratories, Inc.




Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.